YIELD10 BIOSCI Revenue, Profits - YTEN Quarterly Income Statement

Add to My Stocks
$1.69 $0 (0%) YTEN stock closing price Apr 23, 2018 (Closing)

YTEN stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the YIELD10 BIOSCI stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2017 Q4 impacts the YTEN stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2017 Q4 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest YIELD10 BIOSCI profit and loss statement with those of the prior corresponding period. Also see YIELD10 BIOSCI assets and YIELD10 BIOSCI free cash flow for a complete valuation of YTEN stock.

View and download details of revenue and profits for YIELD10 BIOSCI for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
YIELD10 BIOSCI Revenues or Net Sales
------2.79M---
Cost Of Goods Sold (COGS)-----0.23M-----
YIELD10 BIOSCI Gross Profit
-----2.54M-2.67M---
Research & Development Expense1.23M1.13M1.13M1.1M-4.48M1.54M4.28M4.33M4.26M4.08M
Selling General & Admin Expense1.43M1.07M1.86M1.27M-0.13M1.53M1.61M2.72M2.03M2.15M
Income Before Depreciation Depletion Amortization-2.53M-1.98M-2.71M-2.06M2.09M-2.6M-3.23M-6.5M-5.91M-5.88M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M-0.04M-0.01M-0.03M-0.06M-0.01M---0.01M-
Interest Expense----------
YIELD10 BIOSCI Pretax Income
-2.56M-2.02M-2.72M-2.09M2.01M-2.61M-3.19M-6.49M-5.93M-5.84M
Provision for Income Taxes-----0.05M-1.04M----
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-2.55M-2.03M-2.73M-2.09M-1.57M-1.49M-3.2M-6.5M-5.92M-5.85M
Extraordinary Items & Discontinued Operations-----0.36M5.51M----
YIELD10 BIOSCI Profit/ Loss (Net Income)
-2.55M-2.03M-2.73M-2.09M-1.93M4.02M-3.2M-6.5M-5.92M-5.85M
Average Shares used to compute Diluted EPS4.04M3.41M2.85M2.84M2.83M2.79M2.77M2.74M2.73M2.7M
Average Shares used to compute Basic EPS4.04M3.41M2.85M2.84M2.83M2.79M2.77M2.74M2.73M2.7M
Income Before Nonrecurring Items-2.55M-2.03M-2.73M-2.09M-1.57M-1.49M-3.2M-6.5M-5.92M-5.85M
Income from Nonrecurring Items----------
YIELD10 BIOSCI Earnings Per Share Basic Net
-0.99-0.59-0.96-0.70-0.701.40-1.20-2.40-2.20-2.20
YIELD10 BIOSCI Earnings Per Share Diluted Net
-0.99-0.59-0.96-0.70-0.701.40-1.20-2.40-2.20-2.20
EPS Diluted Before Nonrecurring Items-0.99-0.59-0.96-0.70-0.60-0.50-1.20-2.40-2.20-2.20
Preferred Dividends Acc Pd1.45M---------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Honeywell financial analysis

It is very helpful to read a report on YIELD10 BIOSCI stock analysis. An investor must check the following items in an income statement:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that YTEN stock has a topline or revenue of $- for 2017 Q4 as per this YIELD10 BIOSCI revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. YTEN stock had a poor bottom line growth.

The income statement is also called statement of revenue and expense. The YTEN financials along with YIELD10 BIOSCI historical stock prices provide a lot of details about the firm.

YIELD10 BIOSCI Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
7.33
Dividend Yield
0%